RELUEASE 40/1/0.5MG TABLET

Form: Tablets

Pack Size: 10 TABLETS

Marketed by: SUN PHARMACEUTICAL INDUSTRIES LTD (ONCOLOGY DIV)

MRP: ₹1312.50

SUN PHARMACEUTICAL INDUSTRIES LTD (ONCOLOGY DIV): Reluease 40/1/0.5MG Tablet, 10 tablets, salt relugolix 40/1/0.5mg. Its MRP stays at Rs 1,312.50 in NPPA's 09-11-2026 anti-cancer trade-margin revision; trade rate Rs 1,000. Group: oral GnRH antagonist (hormone therapy). Same salt is also supplied by Alembic, Mankind. Handling/counselling: check the strength: 120 mg is the prostate-cancer product. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.